COMP <GO>
CATX vs OGI // ALTMAN Z-SCORE & DEBT/EQUITY
Perspective Therapeutics Inc. (NYSE) VS. Organigram Global Inc. (NASDAQ) • 15-METRIC TALLY: CATX 0
— OGI 2
■ METRIC PARITY
LAST: $1.04 (-9.56%) • MKT CAP: $131.3M
balance-sheet
—
LAST: $0.97 (+3.43%) • MKT CAP: $131.6M
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CATX VS. OGI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CATX | OGI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 22.4 | 41.6 | -19.20 | OGI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $131.3M | $131.6M | -$298.8K | OGI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CATX REV | OGI REV | CATX GROSS % | OGI GROSS % | CATX FCF | OGI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $318.0M | — | — | — | -$95.2M | — |
| FY 2024 | $254.5M | — | — | — | -$72.7M | — |
| FY 2023 | $114.6M | — | — | — | -$36.9M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CATX // BETA —
OGI // BETA —